No Article Content Available for Insurance Analysis
No content available to summarize relevant U.S. insurance industry news, regulatory updates, or market insights.
CMS Excludes Oxygen and CPAP Supplies from 2026 Medicare Competitive Bidding
CMS excludes supplemental oxygen and CPAP devices from 2026 Medicare competitive bidding, preserving access to respiratory therapies for 1.5M Americans amid policy reforms.
Winter Wonderfest Event Supports Pediatric Oncology Charity with Community Donations
Join Winter Wonderfest to support The Pediatric Oncology Treasure Chest Foundation through toy and gift card donations. Learn about community events and Medicare Supplement plans in Chicago.
CMS Proposes Major Changes to Medicare Advantage and Part D for 2027
CMS's 2027 Proposed Rule introduces major Medicare Advantage and Part D program reforms including Star Ratings revisions, risk adjustment data access expansion, marketing rules relaxation, and new special enrollment periods for provider terminations.
Medicare Advantage Employer-Group Market Reaches 35.2M Enrollments in 2025
Explore the latest Medicare Advantage employer-group enrollment trends in 2025 with insights from Mark Farrah Associates based on CMS data, highlighting MA-EGWPs market share and regional dynamics.
No Article Content Available for Summary
No article content was provided to generate a professional insurance article summary. Please provide the full text for analysis and SEO rewriting.
2026 Medicare Physician Fee Schedule Updates: Efficiency and Payment Reforms
Explore key 2026 Medicare Physician Fee Schedule updates, including efficiency adjustments, practice expense reforms, and impacts on primary care and subspecialties under CMS policies.
Congress Extends Medicare Telehealth Flexibilities Post-Government Shutdown
The 2025 appropriations act retroactively extends Medicare telehealth flexibilities through January 2026, ensuring provider reimbursement and clear CMS guidance after the federal government shutdown.
Navigating VA and Medicare Benefits for Veterans Turning 65 in 2026
Explore how veterans turning 65 can effectively navigate VA and Medicare benefits in 2026, understanding costs, coverage differences, and enrollment strategies to optimize healthcare access and minimize expenses.
Biosimilar Bevacizumab Enables Medicare Cost Savings, Expands Cancer Treatment Access
Study shows biosimilar bevacizumab reduces Medicare costs for metastatic colorectal and lung cancer treatments, expanding patient access without raising spending.